Tag: WHO

  • Trump withdraws US from WHO over pandemic response

    Trump withdraws US from WHO over pandemic response

    President Donald Trump has announced the United States is withdrawing from the World Health Organisation (WHO), a significant decision that sparked criticism from public health experts on his first day back in the White House.

    Trump has been a long-standing critic of the United Nations health agency. 

    His administration initially began the withdrawal process in July 2020, during the height of the Covid-19 pandemic. 

    However, the move was reversed in early 2021 by President Joe Biden, who prioritized keeping the U.S. engaged with the global health body in one of his first executive actions.

    Read Also: Trump pledges to return criminal aliens back, reduce costs of living, others

    The new executive order outlines the reasons for the withdrawal, citing the WHO’s “mishandling of the COVID-19 pandemic that emerged in Wuhan, China, its failure to implement critical reforms, and its susceptibility to political influence from member states.”

    As Trump signed the order, he remarked to an aide, “That’s a big one,” referencing his 2020 decision and reiterating concerns over the disproportionate financial contributions made by the U.S. compared to other nations. In 2020, Trump frequently accused the WHO of assisting China in allegedly obscuring the origins of Covid-19 and enabling its global spread.

  • WHO raises the alarm over global genital herpes infections 

    WHO raises the alarm over global genital herpes infections 

    The World Health Organization (WHO) has disclosed staggering new figures on the prevalence of genital herpes, revealing that over 846 million people aged 15 to 49—more than one in five individuals in this age group globally—are living with the infection.

    The alarming statistics is part of a report released by WHO on Wednesday, which also estimates that 42 million people acquire a new genital herpes infection annually—equivalent to one new case every second.

    While many infections remain asymptomatic, a significant number of individuals experience painful genital sores and recurring blisters, which can disrupt daily life and require frequent medical intervention.

    Director of WHO’s Global HIV, Hepatitis, and Sexually Transmitted Infections Programmes, Dr. Meg Doherty, stressed the urgent need for enhanced prevention and treatment strategies to curb the transmission of herpes. 

    She added that addressing genital herpes could also have a ripple effect in reducing the spread of HIV.

    A Medical Officer within WHO’s Department of Sexual and Reproductive Health and Research,Sami Gottlieb, highlighted the pervasive stigma associated with genital herpes. 

    Read Also: Bayelsa partners UNICEF, WHO, others, launches maternal newborn child health week

    The stigma, she said, has hindered open conversations and robust efforts to combat the infection despite its widespread impact.

    “Expanded research and investment in developing new herpes vaccines and therapies, alongside their equitable distribution, are critical to improving the quality of life for millions worldwide,” Gottlieb emphasized.

    Although condoms are not entirely effective in preventing herpes transmission, Gottlieb noted that consistent and correct usage significantly reduces risk. 

    She also advised individuals experiencing active symptoms to abstain from sexual activity, as the infection is most contagious during outbreaks.

    The WHO recommends HIV testing for those with genital herpes symptoms and, if necessary, pre-exposure prophylaxis (PrEP) to prevent HIV. 

    These measures align with the organization’s Global Health Sector Strategy on HIV, Viral Hepatitis, and Sexually Transmitted Infections 2022–2030, which aims to increase awareness and improve management of genital herpes.

    The report underscored the substantial economic toll of genital herpes, with annual costs estimated at $35 billion globally. This includes healthcare expenses and productivity losses associated with the infection.

    To address these challenges, WHO has called for heightened awareness, broader access to antiviral medications, and strengthened integration of herpes prevention with HIV initiatives.

    “Genital herpes is not just a personal health issue; it’s a global health priority requiring urgent attention and action,” Gottlieb concluded.

  • Bayelsa partners UNICEF, WHO, others, launches maternal newborn child health week

    Bayelsa partners UNICEF, WHO, others, launches maternal newborn child health week

    The Bayelsa State Ministry of Health, in partnership with UNICEF, the World Health Organisation (WHO), and other key stakeholders, has launched the second phase of the Maternal Newborn Child Health Week across the state.

    The event, held at the Agudama-Epie Primary Health Centre in Yenagoa, the state capital, marks the start of a week-long initiative aimed at improving healthcare for mothers and children.

    Speaking at the flag-off, Commissioner for Health, Prof. Seiyefa Brisibe, emphasized the programme’s importance, particularly in enhancing postnatal care for mothers and their newborns.

    He stated: “When our mothers and children are healthy, then we are all happy,” emphasizing the initiative’s aim to improve safety at primary healthcare centres throughout the state.

    Prof. Brisibe noted that a three-day immunisation exercise had recently been conducted for children aged 5 to 11 years, further reinforcing the state’s commitment to child health.

    The Commissioner urged paramount rulers, opinion leaders, and chiefs to advocate for the programme within their communities to ensure its success and optimize healthcare delivery services.

    Also speaking, Dr. Williams Appah, the Executive Secretary of the Bayelsa State Primary Health Care Board, echoed the importance of the day, stating it represented a significant advancement in maternal and child healthcare in the state. 

    He reiterated the campaign’s objective that every childbirth should be safe and appealed to the public to embrace preventive health messages from the state government.

    Dr. Appah lamented the alarming statistic of over 200 maternal deaths during childbirth each year in the state, calling for collective efforts to reduce this figure. 

    He emphasized that such losses were unacceptable and encouraged all stakeholders to take active roles in improving maternal and child health outcomes.

    Read Also: UNICEF, GAVI lift Bayelsa health centers with modern medical equipment

    He urged every parent to prepare their children to participate in the impactful interventions provided through this initiative, stressing the vital need for community involvement for the programme’s success.

    He said the initiative reflects the commitment of the Bayelsa State government and its partners to improve maternal and child health, promote safe childbirth, and foster healthier communities.

    Giving the health benefits of the MNCHW, State Nutrition Officer and Director of Nutrition, Ministry of Health, Mr. Idisi Yibatama, noted that the exercise was to deliver a high medical intervention within the one week period to the mother and child.

    He encouraged mothers to engage in exclusive breast feeding of their babies, adding that it makes the child to grow healthy.

    He also gave health education for some household practices to be observed.

    Other benefits of the exercise, he also noted, were malaria prevention and testing, birth registration, normal routine immunization as well as to introduce multi-nutritional supplements.

    In their goodwill messages, representatives of UNICEF, WHO, Corona Management and Zipline, thanked all and expressed hope that the campaign’s target of the mother and child would be achieved.

    They expressed happiness for supporting the exercise, highlighting that every mother and child should have access to the health commodities.

    They urged everyone to be an ambassador of MNCHW.

  • WHO urges action as diabetes cases surge in Africa

    WHO urges action as diabetes cases surge in Africa

    The World Health Organization (WHO) has called for immediate action to combat the rising diabetes epidemic across Africa, warning that the continent faces devastating health and economic consequences if the trend continues unchecked.

     Currently, more than 24 million adults in Africa are living with diabetes, with half unaware of their condition. The prevalence is projected to double to 54 million by 2045, the highest growth rate globally. WHO attributes this alarming rise to rapid urbanization, sedentary lifestyles, and poor dietary habits.

    The region’s traditionally low investment has hampered Africa’s response to diabetes in chronic disease management. With only 1% of Africa’s health expenditure allocated to diabetes care, the continent lags in addressing the growing burden. This underinvestment risks overwhelming health systems and causing catastrophic financial strain on individuals.

    Read Also: NJC hammers Rivers, Anambra judges over alleged misconduct

    WHO Regional Director for Africa, Matshidiso Moeti, highlighted the continent’s historical focus on combating infectious diseases, leaving health systems ill-prepared to handle chronic conditions like diabetes. These require ongoing care, medication, and lifestyle changes that Africa’s healthcare infrastructure struggles to provide.

    To tackle the crisis, Moeti urged governments and development partners to implement innovative, community-driven solutions. Speaking on the theme of this year’s World Diabetes Day, “Breaking Barriers, Bridging Gaps,” she underscored the need for health system reforms.

     “In August 2024, the WHO Regional Committee for Africa endorsed the Framework for the Implementation of the Global Diabetes Compact (GDC),” Moeti said. “This framework provides a roadmap for strengthening early diagnosis, improving access to essential medicines, and integrating diabetes care into primary health systems across Africa.”

    She called for a united effort involving individuals, communities, and governments to address diabetes prevention and care comprehensively.

  • WHO says millions of children experience daily domestic violence in schools, homes

    WHO says millions of children experience daily domestic violence in schools, homes

    The World Health Organisation (WHO) yesterday said hundreds of millions of children and adolescents around the world face daily violence in their homes, schools, and elsewhere which could have lifelong consequences.

    The violence includes being hit by family members, being bullied at school, as well as physical, emotional, and sexual violence, WHO said.

    Read Also: INEC accredits 111 domestic, international observers to monitor poll

    In most cases, violence occurs behind closed doors.

    More than half of those aged two to 17 or more than a billion minors in total experience violence each year according to the WHO.

    In three out of five children and adolescents, it is physical violence at home, with one in five girls and one in seven boys experiencing sexual violence.

  • Cancer control: FG welcomes IAEA,WHO, IARC countrywide assessment

    Cancer control: FG welcomes IAEA,WHO, IARC countrywide assessment

    The Federal Government has reaffirmed its commitment to addressing the growing challenge of non-communicable diseases (NCDs) through comprehensive measures.

    As part of this effort, external regulatory bodies were invited to evaluate the government’s programs and policies, aiming to gather valuable insights and implement actionable recommendations to enhance the effectiveness of its strategies in tackling NCDs.

    The Minister of State for Health and Social Welfare, Tunji Alausa, emphasised this during a debriefing session with the International Atomic Energy Agency (IAEA), the World Health Organisation (WHO), and the International Agency for Research on Cancer (IARC).

    The visiting Impact Review Mission Team conducted a countrywide assessment of government efforts to combat NCDs.

    “We need international experts like you to assess our cancer control and prevention initiatives and help identify areas for focus,” Alausa said.

    He further underscored the government’s commitment to using expert feedback to refine healthcare strategies, backed by strong political will and prioritisation of healthcare under President Bola Tinubu’s administration.

    While acknowledging the pressing challenges in Nigeria’s cancer care system, particularly the limited availability of critical diagnostic and treatment infrastructure, the Minister stressed that the government cannot afford to be anything but proactive in addressing the issue.

    Read Also: Nigeria halfway through exiting FATF grey list

    “For a country of over 220 million people, we currently have only one positron emission tomography (PET) scanner and no cyclotrons for isotope production.

    “Furthermore, we only have a few linear accelerators,” he said while outlining several strategic initiatives, including addressing the gaps.

    President Tinubu, Alausa noted, has made healthcare a national priority, recently announcing the highest budgetary allocation for the sector in the country’s history.

    This move, according to him, emphasised the administration’s dedication to ensuring that all citizens have access to comprehensive healthcare services.

    “Whenever we approach the President on healthcare issues, he promptly approves our requests, demonstrating his trust in our ability to provide the best care for Nigerians,” Alausa added.

    As part of these efforts, he said the government is establishing six new cancer centers and diagnostic facilities across geopolitical zones, while also strengthening cancer care programs in secondary and tertiary hospitals.

    Also, he said preventive measures, including HPV vaccination and advocacy to raise awareness about cancer care, are also being implemented.

    Despite these initiatives, Alausa acknowledged the challenges facing the healthcare sector, particularly the limited availability of mammogram facilities in public hospitals.

  • Nigeria hosts global summit against cancers, diabetes, cardiovascular diseases, others

    Nigeria hosts global summit against cancers, diabetes, cardiovascular diseases, others

    Nigeria is set to host a global health summit of experts and stakeholders to tackle the rising cases of non-communicable diseases (NCDs), it emerged on Wednesday, October 16.

    The summit, convened by Gatefield, is in response to the alarming spread of NCDs, which have become the leading cause of death worldwide, accounting for 74% of global fatalities.

    According to the World Health Organization (WHO), NCDs kill 41 million people each year, equivalent to 74% of all deaths globally, adding that each year, more than 15 million people die from an NCD between the ages of 30 and 69 years with 85% of the “premature” deaths occurring in low- and middle-income countries.

    NCDs are a significant health problem in Nigeria and the age-standardized mortality rate across four major NCDs (Cardiovascular Disease, Chronic Respiratory Disease, Cancer, and Diabetes) was 565 per 100,000 in males and 546 in females in 2021.

    The event to be held between October 23 and 24 and themed ‘Beyond65: Preventing the Quiet Epidemic’, according to Gatefield will bring together these leading voices to address the escalating crisis of non-communicable diseases (NCDs) such as heart disease, diabetes, and cancer in Nigeria and the sub-Saharan African region, where NCDs account for more than one out of every three deaths.

    In a statement on Wednesday, Gatefield noted that against this backdrop, discussions at the summit will focus on the critical role of fiscal health policies.

    It also revealed that experts would examine critical issues such as the growing obesity epidemic, the burden of caring for people living with non-communicable diseases, and the role of the primary healthcare system in NCD prevention and control.

    Additionally, the experts would address the impact of environmental factors like air quality on public health, aiming to chart a holistic course for relevant government agencies and stakeholders to tackle these issues.

    Read Also: Shell to remain in Nigeria despite divestments

    “Discussions at the summit will focus on policy interventions and innovative approaches to tackle NCDs.

    “Prominently, the event will serve as a platform for the unveiling of Gatefield’s bold new health strategy to extend life expectancy in Africa,” the statement added.

    More than 30 high-profile experts in the field are expected at the summit, including Zainab Shinkafi-Bagudu, the former First Lady of Kebbi State and the President, of the Union for International Cancer Control; Salma Anas, the Special Adviser to Nigeria’s President on Health; Prof. Peter Schwarz, the President of the International Diabetes Federation; and Kristina Sperkova, the President of Movendi International.

    Others are Saeid Tafida, the Africa Regional Coordinator, UNDP, Tax for Sustainable Development Goals; Babatunde Irukera, former Executive Vice-Chairman/CEO, Federal Competition and Consumer Protection Commission; Chief Moji Makanjuola, Chair of the Nigeria Universal Health Coverage Forum; Prof. Barry Popkin of the University of North Carolina; Adamu Umar Alhassan, the President of the Nigeria Cancer Society; Osita Okonkwo, the Country Director of the Nutrition International, Nigeria; and Bintou Camara, the Regional Director of the Africa Program, Campaign for Tobacco-Free Kids, among others

  • WHO decries workplace depression, anxiety-induced $1 trillion, 12 billing workdays loss

    WHO decries workplace depression, anxiety-induced $1 trillion, 12 billing workdays loss

    The World Health Organization (WHO) has highlighted the staggering economic and human cost of workplace-related mental health issues, with global losses reaching $1 trillion and 12 billion workdays annually due to depression and anxiety.

    According to the WHO, mental health challenges in the workplace are driven by factors such as discrimination, poor working conditions, inadequate pay, harassment, bullying, and lack of control over job responsibilities.

    Emphasising that the workplace itself can be a major source of stress, affecting both physical and mental health, the WHO called for an urgent reassessment of work environments and their impact on employee well-being.

    The WHO Regional Director for Africa, Matshidiso Moeti, in her message on Thursday, emphasized the relevance of this year’s World Mental Health Day theme, ‘Healthy Minds at Work, Prioritizing Mental Health in the Workplace’, where she highlighted the challenges faced by workers, particularly the most vulnerable groups, and stressed the urgent need to address these issues.

    World Mental Health Day is commemorated yearly on October 10th to raise awareness of mental health issues worldwide as well as mobilize efforts to support mental well-being.

    In marking World Mental Health Day, Matshidiso Moeti emphasized that this year’s theme, ‘It is Time to Prioritize Mental Health in the Workplace, highlights the significant impact work has on our lives and underscores the urgent need to address mental health in professional environments.

    She said: “A healthy work environment not only provides structure and purpose but also fosters social connections, giving individuals a sense of personal value and identity.

    “However, workplaces can also be significant sources of stress, negatively affecting both physical and mental health.

    “Factors such as discrimination, poor working conditions, being underpaid or undervalued, harassment, bullying, and lack of control can all contribute to mental health challenges at work.

    “Certain workers, such as those in health and emergency services, low-paid or insecure jobs, and casual labour, are particularly vulnerable due to limited support, job security, and legal protections.

    “On the flip side, poor mental health can lead to reduced productivity, absenteeism, and higher staff turnover.

    “Depression and anxiety result in the loss of approximately 12 billion workdays globally each year, costing the global economy around $1 trillion.

    “Additionally, people with severe mental health conditions are often excluded from employment or face inequality and stigma in the workplace.

    “Despite these challenges, only 8 of the 47 countries in the WHO African Region reported having mental health promotion programs in workplaces by 2020, and only 3 had active collaborations between mental health services and labour departments.

    “Urgent action is needed to protect, promote, and support mental health in the workplace. WHO, through its guidelines on mental health at work and in collaboration with the International Labor Organization, recommends key actions for governments, employers, and other stakeholders”.

    To address the issue, she said the government to review and implement employment and health policies that ensure parity between mental and physical health in collaboration with workers’ organizations; and align employment laws with international human rights treaties to prevent discrimination against workers with mental health conditions; establish pathways between health, social, and employment services to facilitate supported employment and return-to-work programs; and build capacity in primary care, occupational health, and mental health services to address mental health conditions at work.

    Read Also: Rita Edochie slams women who tolerate toxic, cheating partners for money

    In addition, the WHO chief also urged employers to incorporate mental health as a core component of occupational safety and health systems; develop specific mental health policies and programs based on WHO recommendations, including training for managers and workers; equip managers to identify and address stressors, support their teams, and manage their stress; and offer reasonable accommodations to support workers with mental health conditions.

    However, workers were also advised to prioritize their mental health, learn stress management techniques, strive for a balanced lifestyle recognize signs when mental health is declining, and seek support from trusted individuals, colleagues, or health professionals.

    “As we celebrate World Mental Health Day, let’s commit to investing in mental health in the workplace because investing in people is the best investment any organization can make.

    “A mentally healthy workforce is engaged, innovative, motivated, and productive, contributing to the success of any organization,” Moeti admonished.

  • Real Pharmaceutical donates drugs to states  with Cholera outbreaks 

    Real Pharmaceutical donates drugs to states  with Cholera outbreaks 

    In response to the rising Cholera outbreaks affecting several states across the country, Reals Pharmaceutical Ltd, a leading pharmaceutical company, has donated hundreds of life-saving drugs to the impacted regions.

    The donation comes at a crucial moment as many states struggle with the health crisis, which has reportedly claimed hundreds of lives and overwhelmed healthcare systems in affected areas.

    Cholera, an acute diarrheal disease caused by consuming contaminated food or water, remains a persistent challenge in Nigeria, especially in regions with poor sanitation and limited access to clean water.

     According to Nigeria Center for Disease Control (NCDC), the 2024 outbreak has been specifically severe, with over 4,809 suspected cases, resulting in 156 deaths that have been recorded across the federation especially, in the most affected areas. 

    The alarming situation underscores the Federal Government’s and international organizations’—including the World Health Organization (WHO)—call for urgent medical supplies, clean water, and improved sanitation to curb the spread of the disease.

    In response, and as part of its Corporate Social Responsibility, Reals Pharmaceutical Ltd stepped in to provide relief by donating its ready-to-drink Oral Rehydration Solution (ORS) known as “Electrorush” to the hardest-hit states.

    According to a statement from the company’s management, arrangements have been finalized to carry out this CSR initiative in Borno and Adamawa States, with plans to donate “Electrorush” to regions where cholera outbreaks continue to threaten public health.

    Read Also: Cholera outbreak: 287,708 people vaccinated in Borno – Commissioner

    This effort aims not only to improve public health in these states but also to aid in the treatment of those affected by the disease and reduce mortality rates. Recently, the company visited Ebonyi State to donate 600 packs of “Electrorush” to the state government, supporting the treatment of patients suffering from the ongoing cholera outbreak. 

    The contribution is part of the company’s wider commitment to easing the impact of cholera in the most affected regions.

     Presenting the drug at the Ebonyi State Ministry of Health in Abakaliki, the Group Managing Director, Ade Popoola, who was represented by Business Manager East, Lucky Uwajei stated that the donation was part of Reals’ Corporate Social Responsibility and will help those affected by the disease.

     “In line with our commitment to supporting public health initiatives, Reals Pharmaceutical Limited is pleased to offer a substantial donation of Electrorush, the first ready-to-drink oral rehydration solution (ORS) in Nigeria.

    “We understand the vital importance of rehydration in the treatment of cholera, particularly in preventing dehydration associated with acute diarrhoea.

    “Electrorush is particularly formulated to provide immediate hydration and assist in recovery during diarrhoea episodes, making it an essential resource in this challenging time.

     “We look forward to collaborating with your office and the director of Pharmaceutical Services to ensure that these donations effectively reach the communities most impacted by the outbreak,” the MD stated. 

    Receiving the donation on behalf of the state government, the Commissioner for Health, Moses Ekuma said Ebonyi state is in a difficult period because of the outbreak of cholera. 

    He  said: “It just came suddenly. Of course, we have been witnessing such in the past but this year it came in a bigger magnitude. 

     “This drink is very important because one problem we have with sachet ORS is that either it is over-diluted or under-diluted and either of those is not good. The quality of water is also not guaranteed.

    “After all, it must cause some problems. But this Electrorush is wonderful because you don’t need any dilution again, you just open and drink.” Electrorush is a scientifically formulated, ready-to-drink Oral Rehydration Solution (ORS) designed to address the limitations of sachet ORS. 

    “By providing a pre-mixed, ready-to-consume solution, Electrorush offers benefits such as immediate rehydration, safety, convenience and effectiveness in cholera treatment. 

    “It’s also pleasantly tasting for Children. Through these donations, Reals Pharmaceutical aims to provide a swift and effective response to the public health crises facing these states.”

    The company noted that it remains committed to partnering with governments and health authorities to ensure access to life-saving rehydration solutions, helping communities combat preventable diseases like Cholera.

  • Swipha gets WHO’s prequalification for two products in West, Central Africa

    Swipha gets WHO’s prequalification for two products in West, Central Africa

    The Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye, has said Swiss Pharma Nigeria Limited (Swipha) is the first indigenous pharmaceutical company in West and Central Africa to secure the World Health Organisation (WHO) prequalification for two products within 15 months.

    Swipha, a leading player in Nigeria’s pharmaceutical industry, recently achieved WHO prequalification for its Sulphadoxine/Pyrimethamine 500/25mg tablet, used for preventing malaria in pregnancy.

    The milestone followed the WHO’s earlier addition of Swipha’s Pediatric Zinc Sulphate 20mg dispersible tablet to its list of prequalified medicines on May 2 of the previous year.

    Read Also: Tinubu hails judicial contributions to national growth, development

    Addressing reporters in Lagos, Adeyeye lauded Swipha’s accomplishments, highlighting the significance of this recognition.

    “Swiss Pharma has once again set a new benchmark. Having been the first manufacturer in West Africa to be recognised by the WHO for compliance with GMP standards in 2013, Swipha has now achieved another first by becoming the initial pharmaceutical company in West and Central Africa to secure prequalification for two products within just 15 months,” she said.

    Adeyeye explained that NAFDAC’s GMP inspectors provided extensive technical support to Swipha in preparation for the WHO’s site inspection. The support, the agency boss said, included an in-depth review of the Corrective and Preventive Actions (CAPA) undertaken to address minor non-conformances identified during the inspection. The collaboration also involved multiple meetings – in-person and virtual – with key Swipha personnel.